Speakers

Meet the World-Class Speaker Faculty Driving Innovation in Ophthalmic Gene Therapy

Abraham Scaria

Chief Scientific Officer

Beacon Therapeutics

Aniz Girach

Chief Medical Officer

Splice Bio

Arun Upadhyay

Chief Scientific Officer

Ocugen

Christopher Chavez

Vice President, Research & Development

Visgenx Inc.

Claire Gelfman

Chief Scientific Officer

Foundation Fighting Blindness

Emily Warner

Principal Scientist

Ikarovec

Eric Kelsic

Founder & Chief Executive Officer

Dyno Therapeutics

Hanen Khabou

Senior Scientist

SparingVision

Hemant Khanna

Vice President, Preclinical Ocular Research

Astellas

Jean Chang

Vice President, Clinical Operations

Nanoscope Therapeutics Inc.

Josefina Nilsson

Chief Executive Officer

QuTEM

Kali Stasi

Senior Vice President, Clinical Development

Adverum

Kenji Fujita

Chief Medical Officer

Atsena Therapeutics

Maryam Moktarzadeh

Senior Director, Regulatory Strategy

REGENXBIO

Melissa Calton

Vice President, Early-Stage Product Development

4D Molecular Therapeutics

Molly Johnson

Director, Data Science

Avista Therapeutics

Moshe Weinstein

Chief Executive Officer, Ophthalmics

Everads-Therapy

Paul Wille

Director, Product Development Process Development

Abeona Therapeutics

Peter Francis

Chief Scientific & Medical Officer

Ray Therapeutics

Rachel Eclov, Gene Therapy for Ophthalmic Disorders

Rachel Eclov

Senior Director - Ophthalmology Development Lead

Kriya Therapeutics

Rob Collin

Chief Scientific Officer

Astherna BV

Stephen Poor

Head of Translational Medicine

Apellis Pharmaceuticals

Viral Kansara

Vice President - Preclinical Development

Clearside Biomedical

Zhongdong Shi

Executive Director & Head of Vector Research & Development Research and Development

Frontera Therapeutics

Register Today
Full Event Program
Partner With Us